o7
82-8000 USAF VIP 747 (POTUS) on descent for JBA from MCAS Yuma
SAM194 USAF C-40B gets in just before POTUS from ground stop at Shannon, Ireland-origin of Vienna, Austria earlier
82-8000 USAF VIP 747 on final approach for JBA (should be on ground by now)
SAM347 USAF G5 returning to JBA after ground stop at MacDill AFB
(not capped)
02-5001 USAFSOC C-32B landed at Ft. Bragg, NC at about 10pm EST-from Idaho Falls
CLUB22 USAF E-4B Nightwatch that escorted the 747's west earlier today on ground at Wright-Patterson AFB, Dayton-OH
02-5001 USAFSOC sw from a short ground stop at Ft. Bragg, NC-back to Eglin AFB
Takeda to sell over-the-counter unit to Blackstone for $2.3bn
Japan's Takeda Pharmaceutical has decided to sell its nonprescription drugs business, including vitamin drug Alinamin, to major U.S. private equity firm Blackstone Group for about 250 billion yen ($2.37 billion). The company intends to reduce debt swollen by Takeda's acquisition of Shire, the U.K. biotech company, and concentrate its management resources on developing prescription drugs, especially cancer treatments.
Takeda Pharmaceutical will sell wholly owned subsidiary Takeda Consumer Healthcare Company, which is involved in Alinamin and the Benza cold medicine line. In fiscal 2019, Takeda Consumer Healthcare posted sales of 64.1 billion yen and an operating profit of 12.9 billion yen.
Takeda, which expects to sign the deal soon, began accepting bids in the spring. Several private equity funds and Japanese pharmaceutical companies showed interest.
https://asia.nikkei.com/Business/Pharmaceuticals/Takeda-to-sell-over-the-counter-unit-to-Blackstone-for-2.3bn
May 9, 2016
Takeda Receives $38 Million Grant from the Bill & Melinda Gates Foundation to Support Polio Eradication in Developing Countries
https://www.takeda.com/newsroom/newsreleases/2016/takeda-receives-$38-million-grant-from-the-bill–melinda-gates-foundation-to-support-polio-eradication-in-developing-countries/
chek't